March 10, 2014

Nutrition 21, announced confidential settlement and license agreement with Pfizer, Wyeth, and Wyeth Consumer Healthcare

JDS Therapeutics, LLC and Nutrition 21, LLC (“Nutrition 21”) announced today that they have entered into a confidential settlement and license agreement with Pfizer, Inc., Wyeth LLC, and Wyeth Consumer Healthcare LLC (“Pfizer”).

DOWNLOAD the PDF
DOWNLOAD the PDF

more news

MORE NEWS
Ingredients

Chromax®Lustriva®Nitrosigine®NooLVL®Velositol®Zinmax®

More

AboutMeet the Sales TeamInnovationQualityProduct ProtectionWhere to FindPress RoomBlogContact

Get in Touch

[email protected]

250 Pehle AvenueSuite 200Saddle Brook, NJ 07663

Nutrition21 Proudly Supports the Following Industry Associations

N21 New Footer Image V2 uai Nutrition21

©2023 Nutrition21, LLC. All rights reserved.       

Nitrosigine®, Velositol®, nooLVL®, Lustriva®, Chromax®, Zinmax®, and their associated logos are registered trademarks of Nutrition21, LLC.  All third party trademarks are the property of their respective owners. Nutrition21, LLC's products are protected by a number of patents including, but not limited to: US Patent Nos. 6,809,115; 6,803,456; 7,576,132; 8,062,677; 8,933,022; 9,028,879; 9,119,835; 9,597,404; 9,675,702; 10,183,049; and 10,245,325.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.